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Abstract
More than 40 years ago, Howard Green’s laboratory developed a
method for long-term expansion of primary human epidermal
keratinocytes by co-culture with 3T3 mouse embryonic fibrob-
lasts. This was a breakthrough for in vitro cultivation of cells
from human skin and later for other epithelia: it led to the first
stem cell therapy using cultured cells and has vastly increased
our understanding of epithelial stem cell biology. In recent years,
new methods to expand epithelial cells as three-dimensional
organoids have provided novel means to investigate the functions
of these cells in health and disease. Here, we outline the history
of stratified epithelial stem cell culture and the application of
cultured epithelial cells in clinical therapies. We further discuss
the derivation of organoids from other types of epithelia and the
challenges that remain for the translation of novel stem cell ther-
apies toward clinical use.
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Introduction
Primary cell culture of human epithelial cells has been possible
since the mid-1970s, but the ability to establish long-term cultures
has varied depending on which organ cells are isolated from.
Nonetheless, research has made considerable progress in under-
standing the mechanisms by which stem and progenitor cells
orchestrate the homeostatic turnover and regenerative potential of
adult epithelia. These cells reside within complex niches throughout
the body that are composed of differentiated epithelial cells, diverse
mesenchymal cells, vasculature, neuronal cells, and surrounding
extracellular matrix (ECM).
Cell culture imposes a very different, harsh environment to
which epithelial cells must adapt and proliferate extensively with-
out losing their functional potential or entering a senescent state.
Defining conditions for expanding primary epithelial cells without
immortalization has been a challenge, but, under the correct condi-
tions, cells can undergo more population doublings than they might
in vivo. Lately, improvements in culture protocols to minimize the
loss of clonogenic cells by maintaining a balance between cell
proliferation and differentiation have allowed the expansion of suf-
ficient numbers of primary human epithelial cells for diverse appli-
cations, including regenerative medicine (De Luca et al, 2006),
disease modeling (Schweiger & Jensen, 2016), toxicology (Hynds &
Giangreco, 2013), and drug discovery (Ranga et al, 2014).
In this Review, we focus on the application of cultured epithelial
cells in regenerative medicine. In particular, we discuss the 3T3
mouse embryonic fibroblast (MEF) co-culture system that has
enabled stratified epithelial stem cell therapy for clinical use. We
further discuss recent advances in 3D organoid culture that allow
non-stratified epithelial cell culture and consider the challenges that
these methods face to emulate the translational successes that have
used cultured stratified epithelial cells.
A history of epithelial cell expansion using 3T3 cells
3T3 cells were first isolated in Howard Green’s laboratory in the
early 1960s as part of his experiments to better control the
process of cell line derivation (Fig 1). Mouse embryonic cells
were plated to select for adherent cells after embryo disaggrega-
tion and then expanded for 2–3 days until confluence. Following
this transfer or “passage”, culture conditions—inoculation densi-
ties and transfer frequency—were systematically varied to study
the growth characteristics of murine fibroblasts (Todaro & Green,
1963). Higher inoculation densities increased the possibility of
routine culture establishment, but one cell line was established
from a low-density culture. “3T3” is thus an abbreviation of this
culture protocol—a 3-day transfer period with 3 × 105 cells plated
at each transfer. In common with MEF cultures established using
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other protocols, 3T3 cells developed altered chromosome number
and gross karyotypic abnormalities, but were contact-inhibited
upon cell confluence. Initially, the cells were used in studies
of viral transformation, as loss of contact inhibition can be easily
identified in a confluent monolayer (Todaro & Green, 1966).
Reproduction of the 3T3 protocol in other laboratories led to
isolation of independent 3T3 cell lines from BALB/C and NIH Swiss
mouse strains, giving rise to BALB/3T3 and NIH/3T3 lines, respec-
tively (Aaronson & Todaro, 1968; Jainchill et al, 1969). These lines
differ from the original 3T3 line as they are less contact-inhibited
and more susceptible to viral transformation. Other subclones of
Green’s 3T3 cells were selected for the presence of lipid accumula-
tion. Upon cell confluence, these cells accumulate triglyceride lipids
in cytoplasmic droplets and generate mature fat pads after injection
into athymic mice (Green & Kehinde, 1974, 1979; Green & Meuth,
1974). These cells, known as 3T3-L1, are now widely used to model
adipogenesis.
With regard to epithelial cell expansion in vitro, a key break-
through was made during attempts to derive primary cell cultures
from murine teratomas. When cultured on plastic, these tissues
gave rise to fibroblasts with few, poorly proliferative epithelial cells.
However, co-culture with mitotically inactivated 3T3 cells reduced
fibroblast contamination and enabled serial expansion of epithelial
cells resembling keratinocytes (Rheinwald & Green, 1975a). Applica-
tion of this protocol to human epidermal keratinocytes, which had
until then proven impossible to expand substantially in culture,
created progressively growing, strongly adhesive colonies of epithe-
lial cells that pushed away the surrounding feeder cells (Rheinwald
& Green, 1975b). These colonies are genuine 3D structures that can
display partial stratification, with cells resembling basal cells in
contact with the culture dish.
Both the feeder cells and the culture medium were further opti-
mized for human keratinocyte culture, which now uses 3T3-J2 cells,
a subclone of Green’s 3T3 line that are more supportive of keratino-
cyte cultures (Rheinwald, 1989). Initially, co-cultures were
performed in medium consisting of Dulbecco’s modified Eagle’s
medium (DMEM) and Ham’s F12 in a 3:1 ratio with added fetal
bovine serum (FBS) and hydrocortisone. Later refinements saw the
addition of adenine (Peehl & Ham, 1980), cholera toxin (Green,
1978; Okada et al, 1982), insulin (Tsao et al, 1982), triiodothy-
ronine (Maciag et al, 1981), and epidermal growth factor (Rhein-
wald & Green, 1977). 3T3 co-culture in supplemented FAD (F12,
adenine, and DMEM) medium allowed the long-term expansion of
human epithelial cells for the first time.
Importantly, long-term expansion of epidermal cells in culture is
enabled by the maintenance of epidermal stem cells; this was shown
by seminal experiments that allowed the retrospective identification
of stem cells by analyzing the differential growth capacity of colony-
forming human epidermal cells in vitro (Barrandon & Green, 1987).
When individual colonies formed from a single cell are re-plated in
secondary cultures, they can be classified into three different clonal
types: the “holoclone” has the greatest expansion capacity as at
least 95% of the colonies in secondary cultures are large and
contain small, highly proliferative cells; the “paraclone” gives rise
only to small colonies of cells that undergo terminal differentiation
within a few doublings (< 15); finally, the “meroclone” represents
an intermediate stage between holoclones and paraclones that
contains both types of colonies (Barrandon & Green, 1987). Cells
that form holoclones are the epidermal stem cells that are able to
reconstitute a functional epidermis lasting for a lifetime in the treat-
ment of full-thickness burns (Pellegrini et al, 1999). The number of
holoclones in vivo is affected by aging, whereas loss of stemness in
culture may occur by clonal conversion—from holoclones, through
meroclones to paraclones—during which growth potential progres-
sively decreases and telomere-independent senescence takes hold
(Barrandon et al, 2012).
Clinical translation of epidermal and corneal stem cells
Endogenous regeneration mediated by adult stem cells is not
always capable to completely repair damaged tissue. For example,
Glossary
Clonogenicity
Single epithelial cells have the ability to form clones in culture.
Human epithelial cells are heterogeneous in their capacity to form
clones. Self-renewal and growth potential of the colony-initiating
cell can be inferred by secondary culture of individual clones.
Secondary cultures generating more than 95% of proliferative clones
are “holoclones”, initiated by a stem cell; those generating only
small, abortive colonies that terminally differentiate are
“paraclones”; finally, “meroclones”, whose secondary cultures
contain a mixture of these clonal morphologies, are generated by a
progenitor of an intermediate potency.
Feeder cells
3T3-J2 murine embryonic fibroblasts provide a supportive in vitro
environment for the expansion of human stratified epithelial cells.
Feeder layers are prepared using mitotically inactivated cells and
are gradually outcompeted by growing epithelial cells such that on
confluence they form a negligible component of the final product.
Functionality
In generating epithelia for therapy, it is important to distinguish
stem cell-mediated long-term self-renewal from short-term
epithelial replacement. Epithelial “bandage” approaches involving
transplantation of epithelial cells that were expanded in conditions
that do not allow stem cell retention, might be beneficial to
stimulate endogenous regeneration but, due to the absence of stem
cells, will not themselves maintain the regenerated tissue over the
lifetime of the patient.
Long-term expansion
In optimal culture conditions, epidermal stem cells can be cultured
for more than 4 months of continuous culture during which time
they undergo over 120 population doublings. Important features of
this long-term expansion are the generation of large numbers of
cells for use in therapy (a single epidermal stem cell can generate
sufficient cells to generate grafts to cover the whole body surface)
and the retention of holoclone-forming stem cells throughout the
culture period. These stem cells underlie the long-term therapeutic
benefit of transplanted cultured epidermis.
Stem cell-derived organoids
Literature definitions of the term “organoid” differ in scope. The
term is often used in a broad sense to capture cell culture systems
that are organotypic but here we use it to refer to 3D cultures in
which stem cells initiate epithelial tissue formation that is
maintained over serial passages.
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full-thickness epidermal wounds larger than 4 cm in diameter do
not heal appropriately without medical intervention (MacNeil,
2007). Current therapies involve repair with split-thickness auto-
grafts of epidermis and a thin layer of dermis from a non-affected
body site. However, this approach is poorly suited for extensive
burns and increases the risk of sepsis. The clinical application of
autologous stem cells expanded ex vivo has addressed this problem.
By the early 1980s, pre-clinical work demonstrated that epithelial
sheets could be generated by culturing keratinocyte colonies to
confluence and detaching them using enzymes that target cell–
substrate but not cell–cell junctions, such as dispase (Banks-Schlegel
& Green, 1980) or thermolysin (Germain et al, 1993). Engraftment of
these cultured epidermal autografts (CEAs) on wound beds in
immune-compromised mice was robust, and the histological
morphology of cultured human epidermis remained intact for several
months after transplantation (Banks-Schlegel & Green, 1980).
Initially, two patients received CEAs in combination with
conventional autografts to treat extensive third-degree burns
(O’Connor et al, 1981). Large-scale production followed and two
patients with third-degree burns of more than 80% of the total skin
surface also received CEAs (Gallico et al, 1984). Engraftment was
successful, and around 50% of the life-saving epithelial regeneration
was mediated by cultured cells. Overall, 60–100% of grafts take
(Gallico et al, 1984; Pellegrini et al, 1999), but the success rate is highly
variable between individual patients (De Luca et al, 2006) and grafts
can fail owing to suboptimalwound bed preparation and infection.
An improvement to the CEA protocol has involved culturing kera-
tinocytes on alternative substrates as dispase-mediated detachment
shrinks the epithelial surface area by 50% and generates fragile
epithelial sheets that can only be used during a short window around
the time of cell confluence. These alternative substrates include fib-
rin (Pellegrini et al, 1999; Ronfard et al, 2000), an insoluble protein
























































Figure 1. A timeline of advances in long-term epithelial cell culture.
Images within this figure have been re-used with permission from EMBO Press (EMBO Molecular Medicine; Droz-Georget Lathion et al, 2015), Massachusetts Medical Society
(The New England Journal of Medicine, Gallico et al, 1984), Dove Medical Press (Clinical Ophthalmology, Atallah et al, 2016), Nature Publishing Group (Nature Medicine, Mavilio
et al, 2006; Nature, Sato et al, 2009; Hirsch et al, 2017), and Elsevier (Gastroenterology, Sato et al, 2011a).
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mesh that is formed during normal wound healing, ECM proteins
(Myers et al, 1997; Horch et al, 2000), and chemically defined
surfaces (Zhu et al, 2005), but preservation of epidermal stem cells
has only been demonstrated on tissue-culture plastic and fibrin
substrates. These substrates have multiple advantages as they
remove the need for enzymatic dissociation, retain ECM proteins
produced by epithelial cells, and are more easily manipulated during
surgery. Crucially, substrate-enabled CEAs can be transplanted
subconfluent, which permits a more flexible time window for trans-
plantation. The performance of CEAs was also appreciably improved
by the use of cadaveric skin allografts, which adhere to the wound
bed; the epidermis can be mechanically removed later for CEA
engraftment (Cuono et al, 1986). This reduces the risk of infection
and therefore promotes successful engraftment by maintaining a skin
barrier prior to CEA transplantation and also provides a surgically
prepared wound bed of allodermis.
Clinical experience and post-treatment analysis showed that
CEAs are safe and that the morphological features of epidermis
return, albeit over variable timeframes: scar tissue in the dermal
layer takes up to 5 years to resolve, whereas Langerhans cells are
present within 6 months and melanocytes within a year. Normal
interfollicular epidermal histological appearance is maintained for
many years post-transplantation (Compton et al, 1989; Odessey,
1992). In this way, 3T3 co-culture has benefitted thousands of
patients worldwide (Watt, 2014). However, epidermal appendages
such as hair follicles, sebaceous glands, and sweat glands are not
currently regenerated in CEA skin, although progress has been made
toward understanding the molecular mechanisms that govern their
development (Lu et al, 2016; Chacon-Martinez et al, 2017; Lei et al,
2017) and designing methods to incorporate these into clinical trans-
plants (Higgins et al, 2013).
Notably, CEA transplantation has revealed novel insights into the
extent of epidermal cell plasticity. Palm and sole epidermis for
instance is characterized by a thickened stratum corneum and cyto-
keratin-9 (KRT9) expression, which are not found in epidermis from
other anatomical sites. When palm-derived CEAs were grafted onto a
patient’s upper leg, they retained memory of their site of origin
(Mavilio et al, 2006). Similarly, cultured oral keratinocytes from the
palate preserve donor site characteristics after transplantation (De
Luca et al, 1990). It appears that keratinocyte location specificity is
cell intrinsic and not lost during culture or re-wired by the microen-
vironment following transplantation. The epigenetic mechanisms
underlying this phenomenon are not currently understood.
More recently, CEAs have enabled epithelial gene therapy in
patients with junctional epidermolysis bullosa (JEB), a blistering
disease in which epithelia are inadequately anchored to the base-
ment membrane owing to mutations in genes encoding laminin 332
(LAMA3, LAMB3, and LAMC2). Autologous epidermal keratinocytes
expanded in culture and retrovirally transduced with full-length
LAMB3 have been successfully engrafted as sheets onto surgically
prepared wound beds (Mavilio et al, 2006; Hirsch et al, 2017).
LAMb3 mRNA was detectable in grafts and expression of the trans-
gene allowed proper keratinocyte-basement membrane interaction
via integrin a6b4. Healthy epithelium containing a normal number
of DNP63 isoform a-positive keratinocyte basal cells was regener-
ated in transplanted areas (De Rosa et al, 2014). In a very recent
report, more than 80% of a patient’s total epidermal surface (Hirsch
et al, 2017) was transplanted after in vitro gene correction. This is a
landmark successful ex vivo gene therapy for a genetic disease of
the epithelium. Nevertheless, these gene therapy studies face the
risk that more than one-third of retroviral integration sites can fall
within transcriptionally active genes; however, since long-term
regeneration depends only on a small number of stem cells, the
significance of deleterious insertion sites might be overstated, espe-
cially when balanced with absence of treatment that, in cases like
this, invariably results in the patient’s death. Together, these studies
demonstrate that cultured epithelial cells can engraft and contribute
to long-term regeneration providing that they are given the correct
cues for self-renewal in vitro. Future application of gene editing
technologies, such as adeno-associated viral vectors (AAVs; Melo
et al, 2014) or high-fidelity CRISPR-Cas9 systems (Kleinstiver et al,
2016), could be safe and effective means to generate gene-corrected,
clonally derived CEAs for transplantation but are not yet in clinical
use (Droz-Georget Lathion et al, 2015).
3T3 co-culture is effective for culturing other stratified squamous
epithelia (Romagnoli et al, 1990), most notably for the generation of
corneal epithelium to treat severe ocular burns (Atallah et al, 2016).
Owing to the anatomical location of the stem cells responsible for
maintaining the clear corneal epithelium in the limbus (Cotsarelis
et al, 1989)—the border area between cornea and conjunctiva—
ocular burns can deplete the stem/progenitor population. In their
absence, conjunctival cells migrate across the cornea causing a
connective coverage that leads to complete loss of vision. Limbal
restoration is therefore essential for successful therapy. For patients
with minimal residual limbal tissue or an uninjured eye, limbal stem
cells expanded in culture restore vision upon transplantation (Pelle-
grini et al, 1997; Rama et al, 2010). To date, several hundred
patients have been treated and, in an Italian cohort, vision was
successfully restored in 78% of cases (De Luca et al, 2006).
The most important lesson from these epithelial therapies is
that of stem cell retention during culture. In CEAs and limbal
transplants alike, the retention of stem cells, rather than the histo-
logical appearance of the epithelium in vitro, is the critical indica-
tor for graft success (Pellegrini et al, 1999). If culture is
suboptimal, and stem cells lost by clonal conversion, grafts gener-
ate an atrophic, fragile epithelium that eventually fails due to the
ever-decreasing ability of transplanted cells to maintain epithelial
integrity (Pellegrini et al, 2013). Importantly, a retroviral integra-
tion study of genetically defined clones in engrafted epidermis in
the recent clinical application of CEA technology for JEB clearly
demonstrates that only a small number of transplanted stem cells
maintain long-term regeneration in vivo (Hirsch et al, 2017).
Yet, the retrospective method for identifying stem cells in vitro
by clonal culture is not well suited for monitoring stem cell mainte-
nance in cultures intended for clinical application. As an alternative,
expression levels of the transcription factor P63 are a more direct
method to assess stem cell content, at least in limbal epithelial cell
cultures (Pellegrini et al, 2001; Di Iorio et al, 2005). In mice, P63-
knockouts are born with stratified epithelia consisting of differenti-
ated cell types, but their maintenance of basal epithelial stem cells
is deficient (Yang et al, 1999). There are at least 10 P63 isoforms
classed as either transactivating (TP63) or N-terminal truncated
isoforms (DNP63) each with different C-termini (a, b, c, d, and e;
Mangiulli et al, 2009). The DNP63 isoform a is enriched in stem
cells and is essential for their retention (Blanpain & Fuchs, 2007;
Senoo et al, 2007). Holoclone formation and DNP63 expression
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levels could both be used for clinical quality control (Pellegrini et al,
2013). Recently, a non-invasive, time-lapse imaging method was
developed which determines epidermal stemness during colony
growth through analysis of cell movement; colonies with collective
motion are more likely to be holoclones (Nanba et al, 2015).
Recreating a niche in vitro
3T3 cells: a mechanistic enigma
3T3 co-culture remains the gold standard for stem cell expansion in
many settings as feeder- and serum-free media, which often replace
these with crude bovine pituitary extract (Peehl & Ham, 1980), stim-
ulate proliferation for only short periods. 3T3 co-culture starts with
producing feeder layers by inactivating 3T3 cells with ~60 gray (Gy)
ionizing (gamma) radiation, which causes direct DNA damage
through double-stranded breaks and the generation of free radicals
that interact with DNA, or by treating 3T3 cells with mitomycin C,
which covalently cross-links double-stranded DNA and prevents the
separation of DNA strands during replication. Both methods cause
irreversible cell cycle arrest and altered cellular metabolism; the
inactivated state might be required in its own right for epithelial cell
support (Palechor-Ceron et al, 2013).
Nonetheless, the contribution of 3T3 cells in co-culture is poorly
understood, which explains the difficulties in producing defined
media that fully recapitulate their growth-supportive effects. This
effect is not simply caused by an increase in the overall density of
cells and is fibroblast-specific. Indeed, other strains of MEFs or even
virally transformed 3T3 cells are not supportive of keratinocyte
expansion to the same extent (Green et al, 1977). Although condi-
tioned medium from 3T3 cells also cannot fully reproduce the effect
of co-culture, diffusible factors likely mediate some of their key
effects as separation of epithelial and feeder cells using transwell
membranes allows colony formation (Palechor-Ceron et al, 2013).
Instead, a constant supply of feeder cell factors, which cannot
be recreated using conditioned medium, might be necessary.
Further work is required to assess the effect of cell–cell contact on
clonogenicity.
Previous work has also stressed the importance of reciprocal
signaling between epithelial and feeder cells for optimal culture
conditions. The receptor tyrosine kinase response of epithelial cells
treated with 3T3 fibroblast-conditioned medium is surprisingly
modest (R.E. Hynds, P. Bonfanti, S.M. Janes, unpublished data), but
cultured keratinocytes constitutively produce interleukin-1 (IL-1),
which causes c-JUN-dependent production of proliferation-enhan-
cing growth factors by 3T3 cells, including keratinocyte growth
factor (KGF), granulocyte–macrophage colony-stimulating factor
(GM-CSF), and hepatocyte growth factor (HGF; Szabowski et al,
2000; Schnickmann et al, 2009). Insulin-like growth factors (IGFs)
have also been identified as relevant 3T3 cell factors since IGF inhi-
bition in keratinocytes or replacing 3T3-J2 cells with BALB/3T3
cells, which do not produce IGFs, reduces epithelial proliferation
(Barreca et al, 1992). The secretion of IGF2 in 3T3-J2 cells appears
to be due to their higher expression of the Wnt pathway antagonist
Dact1, which suppresses transforming growth factor-b2 (TGFb2)
production in response to epithelial-derived Wnt signals (Suzuki &
Senoo, 2015). This synergy between epithelial cells and fibroblasts,
along with the fact that xenogeneic proteins bind to and activate
receptors on human epithelial cells with different efficiency to
species-relevant proteins, has complicated studies to unravel the
mechanistic basis of 3T3 co-culture.
A recent protocol to improve multiple feeder-free stratified
epithelial cell culture systems uses A83-01 and DMH-1, inhibitors
that target activin-like kinase (ALK) receptors in the TGFb and BMP
signaling cascades, respectively (Mou et al, 2016). Interestingly, this
raises the possibility that the role of feeder cells might be the elimi-
nation of factors that are detrimental for epithelial cell propagation,
such as TGFb in serum or produced by epithelial cells, rather than
to provide feeder factors. Nevertheless, the ability of feeder-free
systems to preserve stem cells has not been demonstrated and so,
while our understanding of how 3T3-J2 cells support diverse strati-
fied epithelial cells remains limited, this system remains the gold
standard for epidermal and limbal regenerative medicine.
Development of organoid cultures
The term organoid has been applied to organotypic systems that
more closely represent in vivo tissues (Fig 2) than 2D cultures which
often lose key aspects of tissue physiology (Sasai, 2013). The loss of
the complex microenvironment ex vivo leads to less representative
cellular organization or even an inability to initiate cell cultures. By
seeding cells into a 3D matrix in the presence of mesenchyme
(Ootani et al, 2009) or in medium containing epidermal growth
factor (EGF), Noggin and a Wnt pathway potentiator, R-spondin 1
(Sato et al, 2009), epithelial cells can be expanded long term even
from simple epithelia that were traditionally hard to maintain in cell
culture. By way of example, the dependence of LGR5+ gastrointesti-
nal stem cells on Wnt pathway activation has allowed the formula-
tion of media to expand organoids from the human gastrointestinal
tract that retain the crypt–villus architecture of the native intestine
(Sato et al, 2011a). Subsequently, self-renewing organoids have
been derived from organs, including the prostate, liver, and
pancreas, expanding the repertoire of human epithelial tissues from
which primary culture is possible (Clevers, 2016; Kretzschmar &
Clevers, 2016).
There are differences between epithelia that can be cultured as
2D 3T3 co-culture and as 3D organoids. 3T3 cells support long-term
P63+ stratified epithelial stem cell expansion, whereas there are
currently no reports of organoid culture methods to expand strati-
fied epithelia long-term, suggesting that these cells might have dif-
ferent self-renewal requirements. Wnt signaling, an essential
requirement for organoid propagation, is unlikely to be the basis of
3T3 cell keratinocyte support as 3T3-J2 cells express comparable
levels of Wnt proteins to other MEFs that do not support expansion
(Suzuki & Senoo, 2015). Furthermore, Green’s protocol has
remained relatively unchanged between different stratified epithelia,
but the growth requirements for different human simple epithelial
organoids are more diverse.
Organoid cultures have yielded insight into the cellular mecha-
nisms of epithelial homeostasis and helped to elucidate specific
niche factors. For example, small intestinal Paneth cells, an antimi-
crobial-secreting cell population adjacent to LGR5+ stem cells,
produce EGF receptor ligands, Notch ligands, and WNT3, all of
which are essential for stem cell maintenance in small intestinal
organoids (Sato et al, 2011b). c-KIT+/REG4-expressing deep crypt
secretory cells function in a similar manner in the colonic epithe-
lium (Rothenberg et al, 2012; Sasaki et al, 2016). This highlights the
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importance of both secreted and membrane-bound intraepithelial
signals as niche components, in addition to more commonly studied
mesenchymal–epithelial pathways (Farin et al, 2016).
Furthermore, the location specificity of LGR5+ gastrointestinal
tract stem cells is retained during organoid culture (Middendorp
et al, 2014). Consistent with the finding that epidermal stem
cells retain memory of their donor site in clinical studies (Mav-
ilio et al, 2006), murine small intestinal organoids transplanted
into the murine colon retain transcriptional hallmarks of small
intestinal epithelium 4 weeks after engraftment (Fukuda et al,
2014). Expression of colonic epithelium-specific markers after
transplantation of fetal small intestinal organoids suggests that
these cells might be more plastic (Fordham et al, 2013). Overall,
however, existing data do not support the notion that adult stem
cell expansion protocols “reprogram” cells to greater potency but
rather maintain their native identity and functionality.
Despite the rapid progress in organoid technologies, the field is
at a relatively early stage of development in terms of clinical use
(Fig 3); in particular, questions remain as to whether these cells can
maintain tissue homeostasis after transplantation. Experiments
involving transplantation of murine colonic organoids in an acute
colitis model show promising results: organoids derived from a
single stem cell were capable of engrafting, surviving, and contribut-
ing to histologically normal epithelium for more than 25 weeks (Yui
et al, 2012). Data demonstrating engraftment of human organoids in
orthotopic murine transplantation experiments are currently limited
to human hepatic organoids in acute liver injury (Huch et al, 2015).
Transplanted cells differentiated to express hepatocyte markers and
Tissue dissociation

















Figure 2. Strategies of adult stem cell-based epithelial cell culture.
(A) Pathway for isolating human epithelial cells in 3T3 co-culture and methods for their “re-differentiation” in organotypic assays. (B) Pathway for isolating human epithelial
cells as 3D organoids.
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human albumin and alpha-1-antitrypsin could be detected in the
blood of successfully transplanted animals after 120 days. However,
the functionality of the engrafted cells, including their contribution
to the hepatic stem cell pool, was not analyzed.
These initial transplantation experiments have also revealed
practical hurdles for regenerative applications as vast numbers of
organoid-derived cells have enabled only very modest engraftment
rates. Experimentally, this might be addressed by improving the
reproducibility between and within organoid cultures, by enhancing
delivery methods, and by upscaling organoid cultures for medical
applications, particularly within clinically useful timeframes. Over-
all, the evidence for using organoids as a cell source in translational
applications falls short of demonstrating fully functional epithelia
and further pre-clinical animal models should be advanced.
Dependence of cultured epithelial cells on xenogeneic factors
A commonality between 3T3 co-culture and organoid culture
systems is that the gold standard protocols for stem cell culture
depend on murine-derived products. Attempts to replace 3T3 cells
with human feeder cells and/or defined media have been largely
unsuccessful in terms of stem cell maintenance, while the regulatory
environment for cell therapies has changed substantially. Early
grafts from 3T3 co-culture were sanctioned through collective agree-
ment about the scientific rationale by a small number of clinicians
(Green, 2008). More recently, regulatory bodies in the USA and
Europe have classified tissues based on 3T3 co-culture as xeno-
grafts. The use of murine cells and bovine serum raises concerns
about the transmission of infectious agents. It was also suggested
that co-culture of human embryonic stem cells (hESCs) with murine
feeder cells leads the former to incorporate a potentially immuno-
genic non-human sialic acid, Neu5Gc (Martin et al, 2005). However,
it was later shown that human sera do not reduce hESC viability
substantially and that minor effects are independent of cellular
Neu5Gc content (Cerdan et al, 2006). Notably, these concerns are
unsupported by the long-term engraftment and survival of trans-
planted epithelial cells in patients. While adverse events are
reported, these primarily relate to the preparation of the graft site
and the quality of epithelial cells transplanted, rather than the pres-
ence of 3T3 cells, which only account for 0–2% of cells in the final
CEA product (Ronfard et al, 2000). Importantly, no tumor develop-
ment has been reported in any patients even after follow-up over
several decades. CEAs have received regulatory approval in a
number of countries including the USA, Japan, and Korea. In
Europe, limbal stem cell therapy was recently approved contingent
upon the generation of a well-characterized 3T3-J2 master cell bank
in which all feeder cells are infection-free and cultured in accor-
dance with Good Manufacturing Practice (Pellegrini et al, 2014).
To make matters more complicated, the interactions between
epithelial cells and the ECM secreted by murine feeder cells in 3T3
co-culture are poorly understood. The complex ECM is known to
contain fibronectin, laminin, and collagen types I, IV, and V (Alitalo
et al, 1982), but their relative importance for epithelial stem cell
retention is not known. Laminin is an interesting candidate: a recent
feeder-free protocol employs laminin-rich conditioned medium from
804G rat bladder carcinoma cells to deposit a substrate for epithelial
cell expansion (Mou et al, 2016) and the common organoid ECM
from murine sarcoma-derived Matrigel contains predominantly
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Figure 3. Milestones in regenerative medicine using cultured epithelial
stem cells.
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1,000 other proteins with variability between batches (Hughes et al,
2010). Laminin 511 has been used as a matrix for feeder-free growth
of pluripotent (Nakagawa et al, 2014) and epithelial cells (Polisetti
et al, 2017) but, overall, the physiological presentation of ECM
secreted by cells seems to be more efficient compared with systems
that use recombinant ECM proteins.
Replacing Matrigel with a better-defined product will be critical
for future translation of human organoids for clinical applications.
The potential use of bovine collagen I as a substitute (Jabaji et al,
2014) might address some concerns, but the conditions for complete
organoid differentiation in collagen gels have not been described
and their effects on the long-term maintenance of stem cells are
unclear. Recent studies have begun to pave the way for Matrigel
replacement with synthetic polymers: one elegant study sets out to
determine minimal in vitro ECM niche requirements using a bottom-
up bioengineering approach (Gjorevski et al, 2016). LGR5+ stem
cells could be maintained in a synthetic RGD-functionalized poly-
ethylene glycol (PEG) hydrogel, but these organoids lacked differen-
tiated cell types. Hydrogel stiffness, communicated through YAP
signaling, was the key determinant of stem cell retention and dif-
ferentiation: an initially stiff matrix was required for stem cell
expansion and subsequent matrix softening allowed differentiated
cell types to emerge. The dynamic biomechanical properties of
Matrigel therefore likely support both stem cell maintenance and
organoid differentiation. A second study, investigating an alternative
synthetic approach based on PEG-4MAL macromer-based hydrogels,
also emphasized the importance of polymer mechanical properties
and showed that these could expand pluripotent cell-derived intesti-
nal organoids that could engraft in vivo (Cruz-Acuna et al, 2017). In
such studies, full biocompatibility and rate of polymer degradation
should be carefully analyzed before clinical translation.
Maintaining stem cells in culture
As discussed above, the abundance of stem cells, or holoclones, in
transplanted skin and corneal grafts determines the long-term
survival of the graft. It might therefore be beneficial to use products
with a high proportion of stem cells. In epidermal 3T3 co-cultures,
partial differentiation of colonies occurs during their expansion,
while the stem cell population is retained by balanced self-renewal
of stem cells. Isolation of these cells in the presence of Rho-asso-
ciated protein kinase inhibition (ROCKi) can improve the number of
cells expanded in culture, potentially including a greater number of
stem cells (Chapman et al, 2010; Terunuma et al, 2010), likely by
decreasing the extent of anoikis in the initial cell suspensions
(Watanabe et al, 2007). Continuous ROCKi or mammalian target of
rapamycin (mTOR) inhibition using rapamycin (Iglesias-Bartolome
et al, 2012) also increase epithelial cell proliferation and reduce
terminal differentiation (McMullan et al, 2003; Nanba et al, 2013)
but, despite evidence that cells expanded with ROCKi can differenti-
ate appropriately in vivo (Butler et al, 2016), the capacity of cells
grown in these conditions to contribute to long-term organ home-
ostasis after transplantation has not yet been shown. This stands in
contrast to Green’s protocol, which has clearly demonstrated this
ability in multiple epithelial cell types.
ROCKi is also used during 3D organoid protocols to improve cell
viability during isolation and transfer but does not significantly alter
the cellular composition of organoids. Multiple groups have
explored strategies to preferentially expand LGR5+ stem cells, rather
than their differentiated progeny, in 3D organoid cultures. Addition
of the Wnt pathway activator CHIR99021 and the histone deacety-
lase inhibitor valproic acid to culture medium favors expansion of
murine Lgr5+ intestinal stem cells over differentiated cell types in
organoid culture (Yin et al, 2014). Interestingly, the combination of
3T3 co-culture and medium with niche factors used in organoid
culture allows long-term, pure expansion of genome-stable human
gastrointestinal stem cells in 2D culture (Wang et al, 2015), suggest-
ing that apico-basal polarity generated in 3D organoid cultures is
key to the emergence of differentiated cell types. It will be important
to establish in pre-clinical transplantation models whether stem cell-
enriched transplants outperform those that contain differentiated
cell types.
Future perspectives
Highly expandable cultures containing epithelial stem cells from a
variety of organs can be established in co-culture with 3T3 cells.
These co-cultures, in combination with organotypic differentiation
assays, already offer a great tool for pre-clinical research, but the
use of murine feeder cells is a limitation for their routine use in ther-
apy. However, since stem cell retention is essential for long-term
integration of cultured epithelia, the premature translation of thera-
pies that attempt to replace components of the culture system with-
out clear evidence that they avoid the loss of stem cells should be
cautioned against. Alternatively, trials should have a clear rationale
for the use of cells that will not support long-term tissue homeosta-
sis. Unraveling the mechanisms involved in 3T3 support of stratified
epithelial stem cells has proved difficult, but it is yielding more
knowledge about basic stem cell biology. The determination of
essential feeder factors and the production of defined growth condi-
tions for pluripotent stem cells give hope that it will be possible to
replace murine feeder cells for epithelial stem cell culture in the
future (Nakagawa et al, 2014).
There is much excitement in regenerative medicine about the
potential clinical use of iPS cells and much progress has been made
toward differentiating these into multiple organ-specific lineages,
including epithelium. Yet, there remain greater hurdles to the use of
iPS-derived organoids compared to tissue-specific, stem cell-derived
cultures, including mutational burden, culture duration,
Pending issues
(i) Safety Issues. Culture systems for stratified epithelial cells that
are not dependent on mouse 3T3 feeder cells would be an impor-
tant step. However, it is crucial that these are demonstrated to
have the equivalent capacity to maintain epithelial stem cells
with long-term in vivo regenerative capacity.
(ii) Clinical relevance of organoids. The application of organoid-
derived epithelial therapies will require the development of
clinical-grade matrices, scaled-up culture platforms, and efficient
transplantation methods.
(iii) Barriers to widespread implementation. The use of autolo-
gous adult stem cells in personalized medicines raises issues
around implementation in large patient cohorts. Currently, the
manufacture of such products is expensive and limited to very
specialized centers.
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differentiation efficacy, epigenetic changes, and ultimate functional-
ity. The impact of culture on the genome of cells is a particular
concern. While the absence of any clinically apparent mutations in
patients receiving cultured epithelial cell grafts to date is encourag-
ing, rare genomic alterations could still occur during expansion.
Initial data suggest that small numbers of de novo mutations are
introduced during organoid culture, but this nevertheless compares
favorably to the number of mutations that are introduced during
induced pluripotent stem (iPS) cell culture (Huch et al, 2015). For
these reasons, adult epithelial cells remain the first choice for clinical
application, but iPS options should be explored if the use of adult
stem cells is not feasible (Bilousova & Roop, 2014). This might
include simple epithelia, cases where adult stem cells have been
destroyed by injury—such as severe bilateral burns of the cornea—
or if whole tissue substitutes (e.g., full-thickness skin) can be devel-
oped (Workman et al, 2017). Overall, the cell culture advances
described here raise the prospect that the translational success
achieved for skin and cornea could be repeated in further epithelial
tissues.
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